Expansion Opportunities Rapid facility expansion with multiple new clinics opened or planned in 2025–2027, including Murfreesboro and Lafayette, signaling growing patient demand and potential for partnering with local hospitals, equipment suppliers, and service vendors to support new centers.

Integrated Care Network Large community-based oncology network connected to OneOncology, enabling cross-referrals, clinical trial access, and shared services; ideal for strategic partnerships in patient access programs, trial enrollment optimization, and centralized telemedicine or pathology services.

Pharmacy and Compliance In-house specialty pharmacy Park Pharmacy with URAC accreditation offers medication access, prior authorization support, co-pay assistance, and 24/7 pharmacist availability; opportunity to upsell ancillary services, patient support programs, and payer-negotiation solutions.

Clinical Research Focus Strong emphasis on molecular diagnostics and a large clinical trial network, including self-administered therapies; potential sales paths include trial patient recruitment services, diagnostic workflow tools, and partnerships for expanding trial sites and data integration.

Community-Oriented Growth Significant patient population impact in Tennessee with nearly half of state cancer patients treated by the practice; opportunities to collaborate on community outreach, education programs, bulk pharma or device procurement, and managed services for rural or underserved clinics.